lnfliximab dose intensification in 17-years old patients with Crohn's disease
Journal Title: Pediatria Współczesna. Gastroenterologia, Hepatologia i Żywienie Dziecka - Year 2007, Vol 9, Issue 3
Abstract
nfliximab is recommended for the treatment of sever, active Crohn's disease (CD) in pediatrie and adolescent patients, who have not responded to conventional therapy. Case report of 17-years old boy with celiac disease and sever CD (A1, L3+L4, B3p) diagnosed at ten ye-ars of age is presented. During the third year of maintenance therapy he lost response to interval of infliximabu infusion. Clinical response was regained after dose intensification by decreasing in interval from eight to four weeks between infliximab infusions. After three months of the intensive treatment with infliximab, patient still remains in clinical remission.
Authors and Affiliations
Małgorzata Sładek
Keywords
Related Articles
- EP ID EP82767
- DOI -
- Views 106
- Downloads 0
Clinical indices in inflammatory bowel diseases in children
Introduction: Inflammatory bowel diseases (IBD) are idiopathic, chronic inflammatory disorders of gastrointestinal tract with characteristic clinical picture. Among IBD the most important entities as regards clinical and...
Wchłanianie żelaza - nieznane właściwości mucyn żołądkowych
Wprowadzenie: Przyjmuje się, że Fe (III) jest przyswajane przez organizm po zredukowaniu do Fe (II). Cel pracy: Badanie połączeń Fe (II) i Fe (III) z mucynami żołądkowymi ze specjacją żelaza. Materiały i metodyka: "Mucin...
Retrospective assessment of qualification criteriaand efficasy of azathioprine therapyfor ulcerative colitis in children - experience of single center
Aim of study: The aim of this study was the assessment of qualifications and efficacy of azathioprine (AZA) treatment in children with ulcerative colitis (UC). Material and methods: 25 patients treated for UC with azathi...
Immunohistochemical and morphometric study of duodenal biopsies from school-aged children with a previous history of cow's milk allergy
Introduction: Adverse reactions to food that result in gastrointestinal symptoms are common in infancy. Recently formal evidence have been found that cow's milk protein sensitive enteropathy may persist in older children...
lnfliximab dose intensification in 17-years old patients with Crohn's disease
nfliximab is recommended for the treatment of sever, active Crohn's disease (CD) in pediatrie and adolescent patients, who have not responded to conventional therapy. Case report of 17-years old boy with celiac disease a...